205 related articles for article (PubMed ID: 27477946)
21. High reliability and sensitivity of the BCR/ABL1 D-FISH test for the detection of BCR/ABL rearrangements.
Pelz AF; Kröning H; Franke A; Wieacker P; Stumm M
Ann Hematol; 2002 Mar; 81(3):147-53. PubMed ID: 11904740
[TBL] [Abstract][Full Text] [Related]
22. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications.
Panani AD
Cancer Lett; 2007 Sep; 255(1):12-25. PubMed ID: 17383090
[TBL] [Abstract][Full Text] [Related]
23. Recurrent Cytogenetic Abnormalities in Myeloproliferative Neoplasms and Chronic Myeloid Leukemia.
Swansbury J
Methods Mol Biol; 2017; 1541():247-256. PubMed ID: 27910028
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH).
Appelmann I; Kreher S; Parmentier S; Wolf HH; Bisping G; Kirschner M; Bergmann F; Schilling K; Brümmendorf TH; Petrides PE; Tiede A; Matzdorff A; Griesshammer M; Riess H; Koschmieder S
Ann Hematol; 2016 Apr; 95(5):707-18. PubMed ID: 26916570
[TBL] [Abstract][Full Text] [Related]
25. Chromosomal abnormalities in transformed Ph-negative myeloproliferative neoplasms are associated to the transformation subtype and independent of JAK2 and the TET2 mutations.
Nguyen-Khac F; Lesty C; Eclache V; Couronné L; Kosmider O; Andrieux J; Collonge-Rame MA; Penther D; Lafage M; Bilhou-Nabera C; Chapiro E; Mozziconacci MJ; Mugneret F; Gachard N; Nadal N; Lippert E; Struski S; Dastugue N; Cabrol C; Bernard OA;
Genes Chromosomes Cancer; 2010 Oct; 49(10):919-27. PubMed ID: 20629097
[TBL] [Abstract][Full Text] [Related]
26. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
Hall J; Foucar K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
[TBL] [Abstract][Full Text] [Related]
27. Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency.
Hochman MJ; Smith BD; Karantanos T; Braunstein EM; Gojo I; Jain T; Streiff MB; Moliterno AR; DeZern AE
Int J Hematol; 2023 Mar; 117(3):456-462. PubMed ID: 36181657
[TBL] [Abstract][Full Text] [Related]
28. Cytogenetics might elucidate the etiology of acute transformation of chronic myeloproliferative syndromes without a Philadelphia chromosome. A brief report from a multicenter study by the Group Français de Cytogénétique Hématologique.
Eur J Haematol; 1989 Jul; 43(1):86-7. PubMed ID: 2670606
[No Abstract] [Full Text] [Related]
29. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
Pikman Y; Levine RL
Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
[TBL] [Abstract][Full Text] [Related]
30. Cytogenetics in the management of multiple Myeloma: The guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Daudignon A; Cuccuini W; Bracquemart C; Godon C; Quilichini B; Penther D
Curr Res Transl Med; 2023; 71(4):103427. PubMed ID: 38035476
[TBL] [Abstract][Full Text] [Related]
31. [Chronic myeloid leukemia--update].
Tobler A; Solenthaler M
Ther Umsch; 2004 Feb; 61(2):143-50. PubMed ID: 15018397
[TBL] [Abstract][Full Text] [Related]
32. [Detection of BCR/ABL fusion gene by fluorescence in situ hybridization and its clinical application].
Zhou RL; Mo YX; Lan M; Lin JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1283-8. PubMed ID: 22040989
[TBL] [Abstract][Full Text] [Related]
33. [Chronic myeloid leukemia without Philadelphia chromosome (Ph-negative CML)].
Haus O
Acta Haematol Pol; 1993; 24(3):221-5. PubMed ID: 8249537
[TBL] [Abstract][Full Text] [Related]
34. Cytogenetics of myeloproliferative neoplasms.
Campbell LJ
Methods Mol Biol; 2011; 730():89-98. PubMed ID: 21431636
[TBL] [Abstract][Full Text] [Related]
35. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
[TBL] [Abstract][Full Text] [Related]
36. [Demonstration of BCR-ABL rearrangement in a patient with apparently Ph-negative chronic myeloid leukemia of 15 years' duration].
Valiente A; Outeriño J; Martín Calderín F; Benítez J
Sangre (Barc); 1990 Dec; 35(6):481-3. PubMed ID: 2087668
[TBL] [Abstract][Full Text] [Related]
37. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes].
Bock O
Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608
[TBL] [Abstract][Full Text] [Related]
38. The diagnosis of BCR/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markers.
Haferlach T; Bacher U; Kern W; Schnittger S; Haferlach C
Ann Hematol; 2008 Jan; 87(1):1-10. PubMed ID: 17938925
[TBL] [Abstract][Full Text] [Related]
39. Ph-positive and -negative myeloproliferative syndromes may co-exist.
Mauro MJ; Loriaux M; Deininger MW
Leukemia; 2004 Jul; 18(7):1305-7. PubMed ID: 15103389
[No Abstract] [Full Text] [Related]
40. Molecular markers for the diagnosis of Philadelphia chromosome negative myeloproliferative disorders.
Klippel S; Pahl HL
Pathol Biol (Paris); 2004 Jun; 52(5):267-74. PubMed ID: 15217712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]